PRESS RELEASE published on 11/25/2025 at 15:44, 9 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.72% stake in Avadel Pharmaceuticals plc as of 24 Nov 2025. Details on securities ownership and derivatives The Vanguard Group, Inc. Stake Disclosure Securities Ownership Derivatives Avadel Pharmaceuticals Plc
BRIEF published on 11/25/2025 at 15:44, 9 months 22 days ago Vanguard's Disclosure on Alphawave IP Group and Qualcomm Takeover Code Securities Disclosure Vanguard Group Qualcomm Alphawave IP
BRIEF published on 11/25/2025 at 15:42, 9 months 22 days ago The Vanguard Group Discloses Significant Stake in Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group
PRESS RELEASE published on 11/25/2025 at 15:42, 9 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.41% interest in Mural Oncology plc as of 24 Nov 2025. No other disclosures made Irish Takeover Panel The Vanguard Group Financial Disclosure Interest Disclosure Mural Oncology Plc
BRIEF published on 11/25/2025 at 15:41, 9 months 22 days ago The Vanguard Group Discloses Position in Petershill Partners The Vanguard Group Takeover Code Stake Disclosure Security Transaction Petershill Partners
PRESS RELEASE published on 11/25/2025 at 15:41, 9 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.33% stake in Greencore Group plc as of 24 Nov 2025. Also making disclosures for Bakkavor Group plc The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Greencore Group Plc Bakkavor Group Plc
BRIEF published on 11/25/2025 at 15:40, 9 months 22 days ago The Vanguard Group Discloses Stake in Bakkavor Group plc Takeover Code Stake Disclosure Vanguard Bakkavor Group Greencore Group
PRESS RELEASE published on 11/25/2025 at 15:40, 9 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% stake in Spire Healthcare Group plc as of 24th November 2025 through Form 8.3 submission Securities Form 8.3 Vanguard Group Stake Disclosure Spire Healthcare Group
BRIEF published on 11/25/2025 at 15:39, 9 months 22 days ago The Vanguard Group, Inc. Discloses Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group Plc
PRESS RELEASE published on 11/25/2025 at 15:39, 9 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses 1.80% stake in Alphawave IP Group plc. Dealings include purchasing 5,083 and selling 56,000 1p ordinary shares The Vanguard Group Ownership Disclosure Financial Disclosure Stock Transactions Alphawave IP Group Plc
Published on 09/18/2026 at 00:55, 3 hours 2 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 3 hours 32 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 5 hours 42 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 5 hours 42 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 5 hours 52 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 8 hours 57 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 8 hours 59 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 9 hours 32 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 9 hours 47 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 10 hours 11 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 10 hours 17 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 10 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 20 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
